Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This study will compare atorvastatin (Lipitor) with a placebo (inactive pill) to see if this
drug reduces heart rhythm abnormalities (arrhythmias) or lung inflammation after thoracic
surgery. Preliminary results suggest that cholesterol lowering drugs (statins) may reduce
problems after surgery such as arrhythmias or lung inflammation which may be serious. This
study will be randomized and double blind, meaning that patients are placed in groups purely
by chance, like flipping a coin. Neither the patient or doctor will know which group the
patient is in.